COMMON STOCK PURCHASE WARRANT SCOPUS BIOPHARMA INC.Common Stock Purchase Warrant • November 1st, 2019 • Scopus BioPharma Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 1st, 2019 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time prior to the close of business on July 31, 2023 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Scopus BioPharma Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of a series of warrants issued in a private placement of the Company's securities (collectively, the “Warrants”).
SERIES X-1 COMMON STOCK PURCHASE WARRANT PAVMED inc.Common Stock Purchase Warrant • December 21st, 2017 • PAVmed Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledDecember 21st, 2017 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time after the later of (i) the date the final stockholder approval has been obtained under Nasdaq Stock Market Rule 5635(d) or a successor rule allowing for the issuance of certain of the Securities being issued under the Purchase Agreement (as defined below) and (ii) October 31, 2018 (the “Initial Exercise Date”) and on or prior to the close of business on April 30, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from PAVmed Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warra
SERIES A-1 COMMON STOCK PURCHASE WARRANT PAVMED inc.Common Stock Purchase Warrant • August 8th, 2017 • PAVmed Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledAugust 8th, 2017 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time after the date the stockholder approval referred to in Section 2 has been obtained and is effective (the “Initial Exercise Date”) and on or prior to the close of business on April 30, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from PAVmed Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock or to exchange this Warrant for Series X Warrants in the form attached as Exhibit A (the “Series X Warrants”) (the Series X Warrants, collectively, the “Exchange Warrants”) as set forth in Section 3. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section
SERIES X COMMON STOCK PURCHASE WARRANT PAVMED inc.Common Stock Purchase Warrant • February 1st, 2017 • PAVmed Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledFebruary 1st, 2017 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time after the later of (i) the date the final stockholder approval has been obtained under Nasdaq Stock Market Rule 5635(d) or a successor rule allowing for the issuance of certain of the Securities being issued under the Purchase Agreement (as defined below) and (ii) October 31, 2018 (the “Initial Exercise Date”) and on or prior to the close of business on April 30, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from PAVmed Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warra